Michael Amoroso compensation by year
PRECISION BIOSCIENCES Summary Compensation Table · all 5 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Salary | $127,273 | $603,563 | $629,917 | $635,000 | $650,875 |
| Bonus | $275,000 | $351,819 | $381,000 | $400,050 | $451,294 |
| Stock awards | $236,996 | $2,119,509 | $967,976 | $3,216,563 | $1,025,086 |
| Option awards | $5,345,670 | $1,269,565 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $23,659 | $60,388 | $59,301 | $62,212 |
| Total | $5,984,939 | $4,368,115 | $2,039,280 | $4,310,914 | $2,189,467 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PRECISION BIOSCIENCES INC DEF 14A filed April 8, 2026, accession 0001140361-26-013757, and prior-year filings. Open the filing on EDGAR.
How this page was built: the PRECISION BIOSCIENCES INC filed document, accession 0001140361-26-013757. Every figure is read from that document and cited to the page and table it appears in. Filed April 8, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 203,390 | $846,102 | — |
| RSU | 138,842 | $577,583 | — |
| RSU | 74,138 | $308,414 | — |
| RSU | 8,888 | $36,974 | — |
| Option | 2,083 | — | $41.40 |
Per the Outstanding Equity Awards at Fiscal Year-End table in PRECISION BIOSCIENCES INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
1 Form 4 line since the FY2025 proxy (filed April 8, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-01 | Grant or award derivative | — | 573,888 | $0.00 | 573,888 |
The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
PRECISION BIOSCIENCES’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michael Amoroso · this page | President, Chief Executive Officer and Director | $2,189,467 |
| Alex Kelly | Chief Financial Officer | $1,134,116 |
| Dario Scimeca | General Counsel and Secretary | $911,641 |
Board service
PRECISION BIOSCIENCES board · FY2021–FY2025How this board is paid
Company policy: PRECISION BIOSCIENCES pays directors a $40,000 cash retainer and $108,150 in RSUs. As stated in PRECISION BIOSCIENCES's FY2025 proxy.
The full PRECISION BIOSCIENCES compensation record
free company briefThis page is one person within PRECISION BIOSCIENCES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order PRECISION BIOSCIENCES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PRECISION BIOSCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order DTIL
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.